Clinical trial
Clinical Association Between Obstructive Sleep Apnea (OSA) and Facial Pigmentation, and the Relation Between OSA and Vasovagal Symptoms With Resulting Smoking Tendency and the Effect of Treatment in Patients Referred for Sleep Study.
NCT06331819 is registered in ClinicalTrials.gov with Jordan Collaborating Cardiology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Association Between Obstructive Sleep Apnea (OSA) and Facial Pigmentation, and the Relation Between OSA and Vasovagal Symptoms With Resulting Smoking Tendency and the Effect of Treatment in Patients Referred for Sleep Study.
- Lead sponsor
- Jordan Collaborating Cardiology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 10, 2024
- Completion date
- March 1, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acanthosis nigricans, obstructive sleep apnea, smoking, vasovagal syncope